Anti obesity drug development: Industry trends in 2024 Gubra Media Centre EASD Could Cagrilintide Reset the Brain's Hunger Switch for Lasting Results? Prime Lab Peptides A first in class antisense oligonucleotide RES 010 (Resalis Therapeutics, Turin, Italy) may complement and enhance the efficacy of antiobesity drugs such as GLP 1 receptor agonists (RAs), preclinical experiments and an ongoing phase Cagrilintide is a long acting amylin analogue a synthetic version of the second hormone your pancreas releases every time you eat. While insulin gets all the attention, amylin controls how full you Cagrilintide 5mg Research Peptide EU Laboratory Grade PRG